Microbot Medical Pioneers the Future of Surgical Robotics
Microbot Medical Inc. (Nasdaq: MBOT) proudly announces a momentous advancement in healthcare technology. Emory University Hospital has made history as the first institution to integrate LIBERTY, the revolutionary Endovascular Robotic System, into its patient care framework. This alliance marks a significant step forward in the field of interventional radiology, a specialty that is both increasingly vital and rapidly evolving.
LIBERTY: A Breakthrough in Medical Robotics
LIBERTY stands out as the only FDA-cleared, single-use, remotely operated robotic system specifically designed for peripheral endovascular procedures. This innovative technology offers precise vascular navigation capabilities, with the added benefits of minimizing radiation exposure and reducing physical strain on healthcare providers. Recently, Microbot initiated a limited market release of LIBERTY, with plans for full market introduction set to coincide with the Society of Interventional Radiology (SIR) conference in April 2026. The anticipation surrounding this launch is palpable, as it promises to enhance market adoption significantly.
Collaborative Efforts to Enhance Patient Care
Emory University Hospital is widely recognized for its excellence in patient care, clinical research, and groundbreaking innovations. With a robust foundation in endovascular and oncology services, the collaboration between Microbot and Emory underscores a mutual commitment to elevating patient outcomes. The technologies provided by LIBERTY will empower clinicians to perform intricate peripheral interventions, such as liver tumor embolization and uterine fibroid embolization, more effectively and efficiently.
Insights from Medical Leaders
Dr. J. David Prologo, division director for Interventional Radiology at Emory University School of Medicine, expressed enthusiasm about integrating LIBERTY into their program. He stated, “Adopting innovative technologies like LIBERTY emphasizes our dedication to leading in technological advancements. Its single-use, remotely operated design offers a scalable and practical robotic approach that aligns with our operational goals and enhances the quality of care.”
Transforming Endovascular Procedures
“This moment represents an extraordinary milestone for Microbot Medical and the surgical robotics industry as a whole,” remarked Harel Gadot, the CEO, President, and Chairman of the company. “With the adoption of the first FDA-cleared, single-use robotic system, we are establishing a new medical robotic category. This accomplishment speaks to the dedication and ongoing progress of our entire team.” He emphasized the enthusiasm demonstrated by Emory’s clinicians for this technology, which promises to provide enhanced access to innovative solutions for both physicians and patients within this rapidly developing field.
About Microbot Medical
Microbot Medical Inc. (NASDAQ: MBOT) is a pioneering medical device company in the commercialization phase, focused on evolving endovascular surgery via cutting-edge robotic solutions. With the unique LIBERTY Endovascular Robotic System, Microbot Medical is at the forefront of innovation, offering the world’s first FDA-cleared single-use robotic device built for enhanced precision, efficiency, and safety in medical practice. The company’s commitment to innovation, underpinned by a robust intellectual property portfolio, positions it for sustained growth in the medical robotics landscape.
Frequently Asked Questions
What is the LIBERTY Endovascular Robotic System?
LIBERTY is a cutting-edge robotic system for peripheral endovascular procedures, designed to enhance precision and reduce radiation exposure.
Where is LIBERTY being adopted first?
Emory University Hospital is the first hospital to integrate the LIBERTY system into its healthcare program.
What advantages does LIBERTY offer healthcare providers?
LIBERTY provides precise vascular navigation while minimizing physical strain on clinicians and reducing patient radiation exposure.
What types of procedures can LIBERTY assist with?
LIBERTY is designed for various peripheral interventions, such as liver tumor and prostate artery embolizations.
How is Microbot Medical contributing to the future of healthcare?
Microbot Medical's innovative technologies are transforming endovascular procedures and advancing the surgical robotics field significantly.
